Bridge expands China operations with new lab
This article was originally published in Scrip
Bridge Laboratories is to start constructing a second Chinese research facility in Beijing in the fourth quarter of this year. The 150,000 sq ft building in the city's Zhongguancun Life Science Park is due for completion, in compliance withUS and international regulatory standards, in the fourth quarter of next year . It will provide a range of preclinical contract services, in areas including toxicology, immunology, vaccines and bioanalyis.. The facility will quadruple the US contract research firm's laboratory space in China, it says.
You may also be interested in...
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.